BRISBANE, Calif.–(BUSINESS WIRE)–Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that Dave Mowry, Chief Executive Officer, and Greg Barker, Vice President, Corporate FP&A, will participate in a fireside chat at the Stephens Annual Investment Conference at 4:00 pm CT on Wednesday, November 16, 2022, at … [Read more…]
BRISBANE, Calif.–(BUSINESS WIRE)–Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that Dave Mowry, Chief Executive Officer, and J. Daniel Plants, Executive Chairperson, will participate in a fireside chat at the Stifel Healthcare Conference at 8:00 am ET on Tuesday, November 15, 2022, at the Lotte … [Read more…]
– Raymond F. Schinazi, Ph.D., to Step Down from Board of Directors and Continue as a Member of the Company’s Scientific Advisory Board (SAB) DURHAM, N.C.–(BUSINESS WIRE)–$DTIL #ARCUS–Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced that Dr. … [Read more…]
ABP-671 effective at lowering serum uric acid, the cause of gout JIANGSU, China–(BUSINESS WIRE)–Atom Bioscience, a clinical stage biotechnology company developing new treatments for inflammatory and metabolic diseases, announced today that it will present final data from its Phase 2a clinical trial of its small molecule URAT1 inhibitor for treatment of chronic gout at the … [Read more…]
— Honorees celebrated for outstanding leadership, philanthropic commitments; real estate, finance, technology, pharma industry leaders gathered at Plaza Hotel— NEW YORK–(BUSINESS WIRE)–American Friends of Rabin Medical Center (AFRMC) is pleased to announce it has honored The Moinian Group Principal Mitchell Moinian with the Yitzhak Rabin Philanthropic Leadership Award at the AFRMC 22nd Annual Gala. Held … [Read more…]
PLANO, Texas–(BUSINESS WIRE)–Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” or “we”), a clinical-stage biopharmaceutical company, today announced that management will participate in the Guggenheim 2022 Immunology & Neurology Conference on November 14 – 15, 2022 in New York, NY, and will participate in the Stifel 2022 Healthcare Conference on November 15 – 16, 2022 … [Read more…]
WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has authorized the repurchase of $4 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date. About Thermo Fisher Scientific Thermo Fisher Scientific … [Read more…]
EndeavorRx®, the world’s first FDA-authorized video game treatment, saw quarter over quarter growth in number of prescribers and volume of prescriptions; Initiated commercial launch in Q3 Raised more than $164 million in gross proceeds with business combination; Akili, Inc. now trading as Nasdaq: AKLI BOSTON–(BUSINESS WIRE)–Akili, Inc. (Nasdaq: AKLI), a leading digital medicine company, today … [Read more…]
BIRMINGHAM, Ala.–(BUSINESS WIRE)–BioGX, a global provider of easy molecular diagnostic solutions since 2007, announced that the US FDA has updated their original (June 29, 2021) Direct Sample Xfree™ COVID-19 Emergency Use Authorization to increase the shelf-life of the assay reagent to 15 months and expand its use to additional real-time PCR platforms, including BioGX’s pixl™ … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Cell Expansion Market by Product, by Cell Type, by Application, by End-User and by Region – Global Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global cell expansion market size is estimated to be USD 15.82 billion in 2021 and is expected to witness a CAGR of 12.85% during the … [Read more…]
